CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 186 filers reported holding CORCEPT THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $5,000 | -98.6% | 275 | -98.3% | 0.00% | -100.0% |
| Q2 2021 | $351,000 | -53.3% | 15,975 | -49.4% | 0.01% | -50.0% |
| Q1 2021 | $751,000 | -8.3% | 31,575 | +0.9% | 0.01% | -20.0% |
| Q4 2020 | $819,000 | +50.3% | 31,300 | 0.0% | 0.02% | +25.0% |
| Q3 2020 | $545,000 | -29.6% | 31,300 | -32.0% | 0.01% | -33.3% |
| Q2 2020 | $774,000 | +21.9% | 46,000 | -13.9% | 0.02% | +5.9% |
| Q1 2020 | $635,000 | -1.7% | 53,400 | 0.0% | 0.02% | +30.8% |
| Q4 2019 | $646,000 | -14.4% | 53,400 | 0.0% | 0.01% | -13.3% |
| Q3 2019 | $755,000 | +51.9% | 53,400 | +19.7% | 0.02% | +50.0% |
| Q2 2019 | $497,000 | -5.2% | 44,600 | 0.0% | 0.01% | -9.1% |
| Q1 2019 | $524,000 | -57.1% | 44,600 | -50.0% | 0.01% | -21.4% |
| Q4 2018 | $1,221,000 | +95.4% | 89,200 | +100.0% | 0.01% | 0.0% |
| Q3 2018 | $625,000 | – | 44,600 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 8,360,485 | $186,021 | 8.91% |
| Novo Holdings A/S | 3,377,768 | $75,155,338 | 5.81% |
| Parallel Advisors, LLC | 3,726,565 | $82,916,071 | 2.67% |
| TANAKA CAPITAL MANAGEMENT INC | 35,539 | $791 | 2.14% |
| S&T BANK/PA | 347,260 | $7,727 | 1.39% |
| FAS Wealth Partners, Inc. | 310,771 | $6,914,655 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,112,500 | 0.83% |
| Granite Investment Partners, LLC | 792,519 | $17,633,548 | 0.70% |
| Bridge City Capital, LLC | 60,632 | $1,349,062 | 0.64% |
| AJ WEALTH STRATEGIES, LLC | 509,934 | $11,346,032 | 0.55% |